The multimodal prospects for neuroprotection and disease modification in epilepsy: Relationship to its challenging neurobiology

Restorative Neurology and Neuroscience

Volumn 28, Issue 3, 2010, Pages 323-348

  Hamed, Sherifa A ^a,b,c  

^a ASSIUT UNIVERSITY   (Egypt)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

epileptogenesis; excitotoxicity; gene therapy; molecular manipulation; Neuroprotection; neurotrophic factors

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ADENOSINE A1 RECEPTOR; ANTICONVULSIVE AGENT; ANTIOXIDANT; CALCIUM; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GLUTAMIC ACID; GROWTH FACTOR; ION CHANNEL; KAINIC ACID; LAMOTRIGINE; LITHIUM CHLORIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTRANSMITTER; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PILOCARPINE; RUFINAMIDE; TIAGABINE; TOPIRAMATE; TRIMETHADIONE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN;

ACID BASE BALANCE; ANTICONVULSANT THERAPY; BRAIN INJURY; CELL THERAPY; DIET THERAPY; DRUG MECHANISM; EPILEPSY; EPILEPTOGENESIS; FEBRILE CONVULSION; GENE INTERACTION; HEAD INJURY; HUMAN; KETOGENIC DIET; MENINGITIS; MITOCHONDRION; NEUROBIOLOGY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEIZURE; TONIC SEIZURE; VITAMIN SUPPLEMENTATION;

ANIMALS; BRAIN; COMBINED MODALITY THERAPY; CYTOPROTECTION; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; MODELS, NEUROLOGICAL; NERVE DEGENERATION;

EID: 77954730564     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: 10.3233/RNN-2010-0537     Document Type: Review

References (215)

1. Aiken, S.P.&Brown,W.M. (2000). Treatment of epilepsy: existing therapies and future developments. Front Biosci, 5, 124-152.
2. Alessio, A., Damasceno, B.P., Camargo, C.H., Kobayashi, E., Guerreiro, C.A. & Cendes, F. (2004). Differences in memory performance and other clinical characteristics in patients with mesial temporal lobe epilepsy with and without hippocampal atrophy. Epilepsy Behav, 5, 22-27.
3. Alvarez-Dolado, M., Calcagnotto, M.E., Karkar, K.M., Southwell, D.G., Jones-Davis, D.M., Estrada, R.C., Rubenstein, J.L., Alvarez-Buylla, A. & Baraban, S.C. (2006). Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain. J Neurosci, 26, 7380-7389.
4. Ambrosio, A.F., Silva, A.P., Araujo, I., Malva, J.O., Soares-da-Silva, P., Carvalho, A.P. & Carvalho, C.M. (2000). Neurotoxic/ neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs. BIA 2-093 and BIA 2-024. Eur J Pharmacol, 406, 191-201.
5. Andre, V., Ferrandon, A., Marescaux, C. & Nehlig, A. (2000). Electroshocks delay seizures and subsequent epileptogenesis but do not prevent neuronal damage in the lithium-pilocarpine model of epilepsy. Epilepsy Res, 42, 7-22.
6. Attwell, P.J.E., Kent, N.S., Jane, D.E., Croucher, M.J. & Bradford, H.F. (1998). Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)- 2-(2′,3′-dicarboxycyclopropyl) glycine (DCG-IV). Brain Res, 805, 138-143.
7. Bahh, B., Auvergne, R., Leŕe, C., Brana, C., Le Gal La Salle, G. & Rougier, A. (2001). Decreased epileptic susceptibility correlates with neuropeptide Y overexpression in a model of tolerance to excitotoxicity. Brain Res, 894, 209-217.
8. Barton, M.E., Klein, B.D.,Wolf, H.H. & White, H.S. (2001). Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Research, 47, 217-227.
9. Blanton, M.G., Loturco, J.J. & Kriegstein, A.R. (1989). Whole-cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J Neurosci Methods, 30, 203-210.
10. Bengzon, J., Kokaia, Z., Elmer, E., Nanbashvili, A., Kokaia, M. & Lindvall, O. (1997). Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA, 94, 10432-10437.
11. Berent-Spillson, A. & Russell, J.W. (2003). Metabotropic glutamate receptor regulation of neuronal cell death. Exp Neurol, 184, S97-S105.
12. Bialer, M., Johannessen, S., Kupferberg, H.J., Levy, R.H., Perucca, E. & Tomson, T. (2004). Progress report on new antiepileptic drugs: a summary of the Seventh EILAT Conference (EILAT VII). Epilepsy Res, 61, 1-48.
13. Bittigau, P., Sifringer, M., Genz, K., Reith, E., Pospischil, D., Govindarajalu, S., Dzietko, M., Pesditschek, S., Mai, I., Dikranian, K., Olney, J.W. & Ikonomidou, C. (2002). Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA, 99, 15089-15094. (Pubitemid 35334614)
14. Blondeau, N., Plamondon, H., Richelme, C., Heurteaux, C. & Lazdunski, M. (2000). KATP channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection. Neuroscience, 100, 465-474.
15. Bradford, H.F. 1995. Glutamate, GABA and epilepsy. Prog Neurobiol, 47, 477-511.
16. Briellmann, R.S., Berkovic, S.F., Syngeniotis, A., King, M.A. & Jackson, G.D. (2002). Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol, 51, 641-644.
17. Brown, W.C. (1953). Properties and alterations of electrically induced seizures in mice. Epilepsia, 2, 127-137.
18. Cavalheiro, E.A., Leite, J.P., Bortolotto, Z.A., Turski, W.A., Ikonomidou, C. & Turski, L. (1991). Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia, 32, 778-782.
19. Cavazos, J.E., Das, I. & Sutula, T.P. (1994). Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J Neurosci, 14, 3106-3121.
20. Cendes, F., Andermann, F., Dubeau, F., Gloor, P., Evans, A., Jones-Gotman, M., Olivier, A., Andermann, E., Robitaille, Y., Lopes-Cendes, I., et al. (1993). Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology, 43, 1083-1087.
21. Center for biomarker in imaging. Massachusetts General Hospital Harvard-M.I.T. Division of Health Sciences and Technology Web site, (2004). Available at: WWW.biomarkers.Org.
22. Chaudhary, G., Malhotra, J., Chaudhari, J.D., Gopinath, G. & Gupta, Y.K. (1999). Effect of different lithium priming schedule on pilocarpine-induced status epilepticus in rats. Methods Find Exp Clin Pharmacol, 21, 21-24.
23. Chen, C.M., Lin, J.K., Liu, S.H. & Lin-Shiau, S.Y. (2008). Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity. J Neurosci Res, 86(12), 2696-2704.
24. Chen, G., Zeng, W.Z., Yuan, P.X., Huang, L.D., Jiang, Y.M., Zhao, Z.H.& Manji, H.K. (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem, 72, 879-882.
25. Cheng, B. & Mattson, M.P. (1994). NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res, 640, 56-67.
26. Cheng, Y., Deshmukh, M., D'Costa, A., Demaro, J.A., Gidday, J.M., Shah, A., Sun, M.F., Jacquin, Y., Johnson, E.M.& Holtzman, D.M. (1998). Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest, 101, 1992-1999.
27. Choi, D.W. (1994). Calcium and excitotoxic neuronal injury. Ann NY Acad Sci, 15, 162-171.
28. Chronopoulos, A., Stafstrom, C., Thurber, S., Hyde, P., Mikati, M. & Holmes, G.L. (1993). Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Epilepsia, 34, 359-366.
29. Chung, S.Y. & Han, S.H. (2003). Melatonin attenuates kainic acidinduced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J Pineal Res, 34(2), 95-102.
30. Commission on Classification and Terminology of the International League Against Epilepsy. (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia, 30, 389-399.
31. Crespel, A., Rigau, V., Coubes, P., Rousset, M.C., de Bock, F., Okano, H., Baldy-Moulinier, M., Bockaert, J.&Lerner-Natoli, M. (2005). Increased number of neural progenitors in human temporal lobe epilepsy. Neurobiol Dis, 19, 436-450.
32. da Silva, A.V., Regondi, M.C., Cavalheiro, E.A. & Spreafico, R. (2005). Disruption of cortical development as a consequence of repetitive pilocarpine-induced status epilepticus in rats. Epilepsia, 46(Suppl 5), 22-30.
33. Dailey, J.W., Cheong, J.H., Ko, K.H., Adams-Curtis, L.E. & Jobe, P.C. (1995). Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response. Neurosci Lett, 195(2), 77-80.
34. Dalby, N.O. & Thomsen, C. (1996). Modulation of seizure activity in mice by metabotropic glutamatergic ligands. J Pharmacol Exp Ther, 276, 512-516.
35. D'Ambrosio, R., Fairbanks, J.P., Fender, J.S., Born, D.E., Doyle, D.L. & Miller, J.W. (2004). Post-traumatic epilepsy following fluid percussion injury in the rat. Brain, 127, 304-314.
36. Dash, P.K., Mach, S.A. & Moore, A.N. (2001). Enhanced neurogenesis in the rodent hippocmpus following traumatic brain injury. J Neurosci Res, 63, 313-319.
37. DeLorenzo, R.J. (1999). Neuroprotection: Implications for the future clinical management of epilepsy, a satellite symposium of the 53rd Annual Meeting of the American Epilepsy Society; Orlando, Fla; Dec. 5, 1999.
38. Du, X.P., Sun, M.Z., Yu, Z.Y., Chen, H.X., Tian, D.S., Xie, M.J. & Wang, W. (2007). Effects of cyclin dependent protein kinase inhibitor olomoucine on the neuronal apoptosis after status epilepticus: experiment with rats. Zhonghua Yi Xue Za Zhi, 87(29), 2025-2029.
39. Dudek, F.E. & Williams, P.A. (2003). Does Neuroprotection Prevent Epileptogenesis? Epilepsy Currents, 3(2), 68-69.
40. Duncan, J. (2002). Neuroimaging methods to evaluate the etiology and consequences of epilepsy. Epilepsy Res, 50(1-2), 131-140
41. Elliott-Hunt, C.R., Kazlauskaite, J., Wilde, G.J.C., Grammatopoulos, D.K. & Hillhouse, E.W. (2002). Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. Journal of Neurochemistry, 80(3), 416-425.
42. Emerson, M.R., Nelson, S.R., Samson, F.E. & Pazdernik, T.L. (1999). Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats. Brain Res, 825, 189-193.
43. Engel, J. Jr. (1998). Etiology as a risk factor for medically refractory epilepsy: A case for early surgical intervention. Neurology, 51, 1243-1244.
44. Engel, J. (2001). Mesial temporal lobe epilepsy: what have we learned? Neuroscientist, 7, 340-352.
45. Engel, J. Jr.,Williamson, P.D. &Wieser, H.-G. (1997). Mesial temporal lobe epilepsy. In: Engel, J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincot-Raven Publishers, pp. 2417-2426.
46. Evans, P.H. (1993). Free radicals in brain metabolism and pathology. Br Med Bull, 49, 577-587.
47. Folbergrov́a, J., Druga, R., Haugvicov́a, R., Mares, P. & Ot́ahal, J. (2008). Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid. Neuropharmacology, 54(4), 665-675.
48. Friedman, L.K., Sperber, E.F., Mosh́e, S.L., Bennett, M.V.&Zukin, R.S. (1997). Developmental regulation of glutamate and GABA( A) receptor gene expression in rat hippocampus following kainate-induced status epilepticus. Dev Neurosci, 19, 529-542.
49. Fuerst, D., Shah, J., Shah, A. & Watson, C. (2003). Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol, 53, 413-416.
50. Furtado, M.A., Braga, G.K., Oliveira, J.A., Del Vecchio, F. & Garcia-Cairasco, R.S. (2002). Behavioral, morphological and electroencephalographic evaluation of seizures induced by intrahippocampal microinjection of pilocarpine. Epilepsia, 43(S5), 37-39.
51. Ginsberg, M.D. & Busto, R. (1989). Rodent models of cerebral ischemia. 20, 1627-1942.
52. Giusti, P., Lipartiti, M., Gusella, M., Floreani, M. & Manev, H. (1997). In vitro and in vivo protective effects of melatonin against glutamate oxidative stress and neurotoxicity. Ann NY Acad Sci, 825, 79-84.
53. Goddard, G.V., McIntyre, D.C. & Leech, C.K. (1969). A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol, 25, 295-330.
54. Golorai, G., Green wood, A.C., Feeney, D.M. & Connor, J.A. (2001). Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury. J Neurosci, 21, 8523-8537.
55. Goodman, J.H. (1998). Experimental models of status epilepticus. In: Peterson SL, Albertson TE. (Eds.), Neuropharmacology Methods in Epilepsy Research. CRC Press, Boca Raton, pp. 95-125.
56. Gruber, B., Greber, S., Rupp, E. & Sperk, G. (1994). Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus, 4, 474-482.
57. Guo, X., Dillman J.F. 3rd, Dawson, V.L. & Dawson, T.M. (2001). Neuroimmunophilins: novel neuroprotective and neuroregenerative targets. Ann Neurol, 50, 6-16.
58. Gupta, M., Gupta, Y.K., Agarwal, S., Aneja, S., Kalaivani, M. & Kohli, K. (2004). Effects of Add-on Melatonin Administration on Antioxidant Enzymes in Children with epilepsy Taking Carbamazepine Monotherapy: A Randomized, Double-blind, Placebo-controlled Trial. Epilepsia, 45(12), 1636-1639.
59. Gupta, Y.K. & Gupta, M. (2006). Post traumatic epilepsy: a review of scientific evidence. Indian J Physiol Pharmacol, 50(1), 7-16.
60. Haas, K.Z., Sperber, E.F., Opanashuk, L.A., Stanton, P.K. &Mosh́e, S.L. (2001). Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling. Hippocampus, 11, 615-625.
61. Halonen, T., Nissinen, J. & Pitkänen, A. (2001). Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats. Neuropharmacology, 40, 536-550.
62. Hamed, S.A. (2007). Neuronal Plasticity: Implications in Epilepsy Progression and Management. Drug Develop Res, 68(8), 498-511.
63. Hamed, S.A. (2009a). The Aspects and Mechanisms of Cognitive Alterations in Epilepsy: The role of antiepileptic medications. CNS neuroscience and therapeutics, 15, 134-156.
64. Hamed, S.A. & Abdellah, M.M. (2004). Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients. Jap J Pharmacol Sci, 96, 349-359
65. Hamed, S.A., Hamed, E.A. & Abdella, M.M. (2009b). Septic encephalopathy: Relationship to serum and cerebrospinal fluid levels of adhesion molecules, lipid peroxides and S-100B protein. Neuropediatrics, 40, 66-72.
66. Hamed, S.A., Hamed, E.A. & Zakari, M.M. (2009c). oxidative stress and S-100B protein in children with bacterial meningitis. BMC Neurology, 9(1), 51.
67. Hauser, W.A. (1997). Incidence and prevalence. In: Engel, J., Pedley, T.A., eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 47-57.
68. Hellier,J.L., Patrylo, P.R., Buckmaster, P.S. & Dudek, F.E. (1998). Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res, 31, 73-84.
69. Helmstaedter, C. (2002). Effects of chronic epilepsy on declarative memory systems. Prog Brain Res, 135, 439-453.
70. Helmstaedter, C., Kurthen, M., Lux, S., Reuber, M. & Elger, C.E. (2003). Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol, 54, 425-432.
71. Hemingway, C., Freeman, J.M., Pillas, D.J. & Pyzik, P.L. (2001). The ketogenic diet: A 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics, 108, 898-905.
72. Hermann, B.P., Seidenberg, M. & Bell, B. (2002).The neurodevelopmental impact of childhood onset temporal lobe epilepsy on brain structure and function and the risk of progressive cognitive effects. Prog Brain Res, 135, 429-438.
73. Hesdorffer, D.C., Logroscino, G., Cascino, G., Annegers, J.F. & Hauser, W.A. (1998). Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology, 50, 735-741.
74. Hokfelt, T. (1999). Neuropeptides in perspective: the last ten years. Neuron, 7, 867-879.
75. Holtzman, D.M. & Lowenstein, D.H. (1995). Selective inhibition of axon outgrowth by antibodies to NGFin a model of temporal lobe epilepsy. J Neurosci, 15, 7062-7070.
76. Hönack, D. & Löscher, W. (1995). Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia, 36, 763-771.
77. Huttenlocher, P.R., de Courten, C., Garey, L.J. & Van der Loos, H. (1982). Synaptogenesis in human visual cortex-evidence for synapse elimination during normal development. Neurosci Lett, 33(3), 247-252
78. Ikonomidou, C., Bosch, C., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T.I., Stefovska, V., Turski, L.&Olney, J.W. (1999). Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science, 283, 70-74. (Pubitemid 29044848)
79. Jackson, G.D., McIntosh, A.M., Briellmann, R.S. & Berkovic, S.F. (1998). Hippocampal sclerosis studied in identical twins. Neurology, 51, 78-84.
80. Jarrett, S.G., Milder, J.B., Liang, L.P. & Patel, M. (2008). The ketogenic diet increases mitochondrial glutathione levels. J Neurochem, 106(3), 1044-1051.
81. Jutila, L., Immonen, A., Partanen, K., Partanen, J., Mervaala, E., Ylinen, A., Alafuzoff, I., Paljärvi, L., Karkola, K., Vapalahti, M. & Pitkänen, A. (2002). Neurobiology of epileptogenesis in the temporal lobe. Adv Tech Stand Neurosurg, 27, 5-22.
82. Kanter-Schlifke, I., Georgievska, B., Kirik, D.&Kokaia, M. (2007). Seizure suppression by GDNF gene therapy in animal models of epilepsy. Mol Ther, 15, 1106-1113.
83. Kelly, M.E. & McIntyre, D.C. (1994). Hippocampal kindling protects several structures from the neuronal damage resulting from kainic acid-induced status epilepticus. Brain Res, 634, 245-256
84. Keyser, J.D., Sulter, G. & Luiten, P.G., (1999). Clinical trials with neuroprotection drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci, 22, 535-540.
85. Kim do, Y. & Rho, J.M. (2008). The ketogenic diet and epilepsy. Curr Opin Clin Nutr Metab Care, 11(2), 113-120.
86. Klitgaard, H., Matagne, A., Gobert, J. & Wulfert, E. (1998). Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol, 353, 191-206.
87. Klitgaard, H., Matagne, A. & Lamberty, Y. (2002). Use of epileptic animals for adverse effect testing. Epilepsy Res, 50, 40-53.
88. Koh, S., Storey, T.W., Santos, T.C., Mian, A.Y. & Cole, A.J. (1999). Early-life seizures in rats increase susceptibility to seizureinduced brain injury in adulthood. Neurology, 53, 915-921.
89. Koh, S., Tibayan, F.D., Simpson, J.N. & Jensen, F.E. (2004). NBQXor topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia, 45, 569-575.
90. Kollevold, T. Immediate and early seizures after head injuries. (1976). J Oslo City Hospital, 26, 99-114.
91. Komatsu, M., Hiramatsu, M., Yokoyama, H. & Willmore, L.J. (1996) Effect of TJ- 960 (a Japanese herbal medicine) on free radical changes within an iron induced focal epileptogenic region in rat brain measured by in vivo L band electron spin resonance. Neurosci Lett, 205, 189-192.
92. Komatsu, M., Hiramatsu, M. &Willmore, L.J. (2000). Zonisamide reduces the increase in 8-hydroxy-2′-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats. Epilepsia, 41, 1091-1094.
93. Kondratyev, A., Sahibzada, N. & Gale, K. (2001). Electroconvulsive shock exposure prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Mol Brain Res, 91, 1-13.
94. Kotapka, M.J., Graham, D.I., Adams, J.H. & Gennarelli, T.A. (1992). Hippocampal pathology in fatal non-missile human head injury. Acta Neuropathol, 83, 530-534.
95. Kotloski, R., Lynch, M., Lauersdorf, S. & Sutula, T. (2002). Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits. Prog Brain Res, 135, 95-110.
96. Lauritzen, I., Blondeau, N., Heurteaux, C., Widmann, C., Romey, G. & Lazdunski, M. (2000). Polyunsaturated fatty acids are potent neuroprotectors. EMBO J, 19, 1784-1793.
97. Lee, J.P., Jeyakumar, M., Gonzalez, R., Takahashi, H., Lee, P.J., Baek, R.C., Clark, D., Rose, H., Fu, G., Clarke, J., McKercher, S., Meerloo, J., Muller, F.J., Park, K.I., Butters, T.D., Dwek, R.A., Schwartz, P., Tong, G.,Wenger, D., Lipton, S.A., Seyfried, T.N., Platt, F.M. & Snyder, E.Y. (2007). Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med, 13(4), 439-447.
98. Lemos, T. & Cavalheiro, E.A. (1995). Suppression of pilocarpineinduced status epilepticus and the late development of epilepsy in rats. Exp Brain Res, 102, 423-428.
99. Lere, C., El Bahh, B., Le Gal La Salle, G. & Rougier, A. (2002). A model of 'epileptic tolerance' for investigating neuroprotection, epileptic susceptibility and gene expression-related plastic changes. Brain Res Protoc, 9, 49-56.
100. Levy, S.L., Burnham, M. & Hwang, P.A. (1990). An evaluation of the anticonvulsant effects of vitamin E. Epilepsy Res, 6, 12-17.
101. Li, T., Steinbeck, J.A., Lusardi, T., Koch, P., Lan, J.Q., Wilz, A., Segschneider, M., Simon, R.P., Brüstle, O. & Boison, D. (2007). Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain, 130, 1276-1288.
102. Liu, R.S., Lemieux, L., Bell, G.S., Hammers, A., Sisodiya, S.M., Bartlett, P.A., Shorvon, S.D., Sander, J.W. & Duncan, J.S. (2003). Progressive neocortical damage in epilepsy. Ann Neurol, 53, 312-324.
103. Liu, Z. & Holmes, G.L. (1997). Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits. Neuroscience, 76, 1129-1138.
104. Lukasiuk, K. & Pitkänen, A. (2004). Large-scale analysis of gene expression in epilepsy research: is synthesis already possible? Neurochem Res, 29, 1169-1178.
105. Löscher, W. (1999). Animal models of epilepsy and epileptic seizures. In: Eadie MJ, Vajda F. (Eds.), Antiepileptic Drugs. Handbook of Experimental Pharmacology. Springer, Berlin, pp. 19-62.
106. Löscher, W. (2002). Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res, 50(1-2), 105-123.
107. Löscher, W. & Rogawski, M.A. (2002). Epilepsy. In: Lodge, D., Danysz, W., Parsons, C.G., Editors, (2002). Ionotropic glutamate receptors as therapeutic target, Graham Publications, Johnson City, TN, pp. 91-132.
108. Manno, I., Antonucci, F., Caleo, M. & Bozzi, Y. (2007). BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus. Neuroreport, 18(4), 373-376. (Pubitemid 46667971)
109. Marini, A.M. & Paul, S.M. (1992). N-Methyl-d-aspartate receptormediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc Natl Acad Sci USA, 89, 6555-6559.
110. Marks, D.A., Kim, J., Spencer, D.D. & Spencer, S.S. (1992). Characteristics of intractable seizures following meningitis and encephalitis. Neurology, 42, 1513-1518.
111. Marksteiner, J. & Sperk, G. (1988). Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold. Neuroscience, 26, 379-385.
112. Masukawa, L.M., Burdette, L.J., McGonigle, P., Wang, H., O'Connor, W., Sperling, M.R., O'Connor, M.J. & Uruno, K. (1999). Physiological and anatomical correlates of the human dentate gyrus: consequences or causes of epilepsy. Adv Neurol, 79, 781-794.
113. Mathern, G.W., Adelson, P.D., Cahan, L.D. & Leite, J.P. (2002). Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog Brain Res, 135, 237-251.
114. Mathern, G.W., Babb, T.L. & Armstrong, D.L. (1997). Hippocampal sclerosis. In: Engel, J.J., Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, pp. 133-155.
115. Mathern, G.W., Babb, T.L., Pretorius, J.K. & Leite, J.P. (1995). Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentate. J Neurosci, 15, 3990-4004.
116. Mathern, G.W., Cifuentes, F., Leite, J.P., Pretorius, J.K. & Babb, T.L. (1993). Hippocampal EEG excitability and chronic spontaneous seizures are associated with aberrant synaptic reorganization in the rat intrahippocampal kainate model. Electroencephalogr Clin Neurophysiol, 87, 326-339.
117. Matoth, I., Pinto, F., Sicsic, C. & Brenner, T. (2000). Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells. Neurosci Res, 33, 209-212.
118. Mattson, M.P. & Cheng, B. (1993). Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke, 24, I136-1140.
119. Mattson, M.P., Lovell, M., Furukawa, A.K. & Markesbery, W.R. (1995). Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca++ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem, 65, 1740-1751.
120. Maxwell, W.L., Dhillon, K., Harper, L., Espin, J., MacIntosh, T.K., Smith, D.H. & Graham, D.I. (2003). There is differential loss of pyramidal cells from the human hippocampus with survival after blunt head injury. J Neuropathol Exp Ther, 62, 272-279.
121. McCloskey, D.P., Hintz, T.M., Pierce, J.P. & Scharfman, H.E. (2006). Stereological methods reveal the robust size and stability of ectopic hilar granule cells after pilocarpine-induced status epilepticus in the adult rat. Eur J Neurosci, 24, 2203-2210.
122. McCloskey, D.P., Croll, S.D. & Scharfman, H.E. (2005). Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J Neurosci, 25(39), 8889-8897.
123. Meldrum, B.S. (1997). Identification and preclinical testing of novel antiepileptic compounds. Epilepsia, 38, S7-S15.
124. Meyerhoff, J.L., Lee, J.K., Rittase, B.W., Tsang, A.Y. & Yourick, D.L. (2004). Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the rat. Brain Res, 1016, 139-144.
125. Miyamoto, M., Ishida, M. & Shinozaki, H. (1997). Anticonvulsive and neuroprotective actions of a potent agonist DCG-IV for group II metabotropic glutamate receptors against intraventricular kainate in the rat. Neuroscience, 77, 131-140.
126. Moody, W.M. (1998). The development of voltage-gated ion channels and its relation to activity-dependent developmental events. Curr Top Dev Biol, 39, 159-185.
127. Moldrich, R.X., Chapman, A.G., De Sarro, G. & Meldrum, B.S. (2003). Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol, 476, 3-16.
128. Mori, N., Wada, J.A., Watanabe, M. & Kumashiro, H. (1991). Increased activity of superoxide dismutase in kindled brain and suppression of kindled seizure following intra-amygdaloid injection of superoxide dismutase in rats. Brain Res, 557, 313-315.
129. Mori, A., Yokoi, I., Noda, Y. & Willmore, L.J. (2004). Natural antioxidants may prevent posttraumatic epilepsy: a proposal based on experimental animal studies. Acta Med Okayama, 58(3), 111-118.
130. Muizelaar, J.P., Marmarou, A., Young, H.F., Choi, S.C., Wolf, A., Schneider, R.L. & Kontos, H.A. (1993). Improving the out come of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase. a phase II trial. J Neurosurg, 78(3), 375-382.
131. Muller-Schwarze, A.B., Tandon, A.B., Liu, Z., Yang, Y., Holmes, G.L. & Stafstrom, C.E. (1999). Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport, 10, 1517-1522.
132. Nicholls, D.G. & Budd, S.L. (1998). Mitochondria and neuronal glutamate excitotoxicity. Biochim Biophys Acta, 1366, 97-112.
133. Noé, F., Nissinen, J., Pitkänen, A., Gobbi, M., Sperk, G., During, M. & Vezzani, A. (2007). Gene therapy in epilepsy: The focus on NPY. Peptides, 28, 377-383.
134. Ongini, E., Adami, M., Ferri, C.&Bertorelli, R. (1997). Adenosine A2A receptors and neuroprotection. Ann N Y Acad Sci, 825, 30-48.
135. Orlando, L.R., Standaert, D.G., Penney, J.B. Jr. & Young, A.B. (1995). Metabotropic receptors in excitotoxicity: (S)-4-carboxy-3- hydroxyphenylglycine (S)-4-C3HPG) protects against rat striatal quinolinic acid lesions. Neurosci Lett, 202, 109-112.
136. Oster, J., Doherty, C., Grant, P.E., Simon, M. & Cole, A.J. (2003). Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia, 44(6), 852-854.
137. Oyegbile, T.O., Dow, C., Jones, J., Bell, B., Rutecki, P., Sheth, R., Seidenberg, M. & Hermann, B.P. (2004). The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy. Neurology, 62, 1736-1742.
138. Pagnin, D., de Queiroz, V., Pini, S. & Cassano, G.B. (2004). Efficacy of ECT in depression: a meta-analytic review. J ECT, 20, 13-20.
139. Pan, J.W., Bebin, E.M., Chu, W.J. & Hetherington, H.P. (1999). Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia, 40, 703-707.
140. Parent, J.M. (2002). The role of seizure-induced neurogenesis in epileptogenesis and brain repair. Epilepsy Res, 50, 179-189.
141. Patel, M. & Li, Q.Y. (2003). Age dependence of seizure-induced oxidative stress. Neuroscience, 118, 431-437.
142. Pitkanen, A. & Kubova, H. (2004). Antiepileptic drugs in neuroprotection. Expert Opin Pharmacother, 5(4), 777-798.
143. Pitkanen, A., Nissinen, J., Nairismagi, J., Lukasiuk, K., Grohn, O.H., Miettinen, R. & Kauppinen, R. (2002). Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res, 135, 67-83.
144. Pitkanen, A. & Sutula, T.P. (2002). Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporallobe epilepsy. Lancet Neurol, 1, 173-181.
145. Pitkänen, A. & McIntosh, T.K. (2006). Animal Models of posttraumatic epilepsy. Journal of Neurotrauma, 23(2), 241-261.
146. Polla, B.S., Kantengwa, S., Francois, D., Salvioli, S., Franceschi, C., Marsac, C. & Cossarizza, A. (1996). Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA, 93, 6458-6463.
147. Prehn, J.H., Bindokas, V.P., Marcuccilli, C.J., Krajewski, S., Reed, J.C.&Miller, R.J. (1994). Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci USA, 91, 12599-12603.
148. Qian, J., Colmers, W.F. & Saggau, P. (1997). Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca++ entry. J Neurosci, 17, 8169-8177.
149. Rakic, P., Bourgeois, J.P., Eckenhoff, M.F., Zecevic, N.&Goldman-Rakic, P.S. (1989). Concurrent overproduction of synapses in diverse regions of primate cortex. Science, 232, 232-235.
150. Reibel, S., Vivien-Roels, B., Le, B.T., Larmet, Y., Carnahan, J., Marescaux, C. & Depaulis, A. (2000). Overexpression of neuropeptide-Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting. Eur J Neurosci, 12, 595-605.
151. Reiter, R.J. (1995). Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J, 9, 526-533.
152. Reiter, R.J., Tang, L., Garcia, J.J.&Munoz-Hoyos, A. (1997). Pharmaco1ogica1 actions of melatonin in oxygen radical pathophysiology. Life Sci, 60, 2255-2271.
153. Rejdak, R., Rejdak, K., Sieklucka-Dziuba, M., Stelmasiak, Z. & Grieb, P. (2001). Brain tolerance and preconditioning. Pol J Pharmacol, 53, 73-79.
154. Ribak, C.E. & Baram, T.Z. (1996). Selective death of hippocampal CA3 pyramidal cells with mossy fiber afferents after CRHinduced status epilepticus in infant rats. Brain Res Dev Brain Res, 91, 245-251.
155. Richichi, C., Lin, E.J., Stefanin, D., Colella, D., Ravizza, T., Grignaschi, G., Veglianese, P., Sperk, G., During, M.J. & Vezzani, A. (2004). Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci, 24(12), 3051-3059.
156. Rigoulot, M.A., Koning, E., Ferrandon, A. & Nehlig, A. (2004). Neuroprotective properties of topiramate in the lithium- pilocarpine model of epilepsy. J Pharmacol Exp Ther, 308, 787-795.
157. Rizzi, M., Perego, C., Aliprandi, M., Richichi, C., Ravizza, T., Colella, D., Velískǒv́a, J., Mosh́e, S.L., De Simoni, M.G. & Vezzani, A. (2003). Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis, 14, 494-503.
158. Rocamora, N., Palacios, J.M. & Mengod, G. (1992). Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus. Mol Brain Res, 13, 27-33.
159. Rufo-Campos, M. (2002). Melatonin and Epilepsy. Rev Neurol, 35(Suppl 1), S51-58.
160. Sankar, R. & Holmes, G.L. (2004). Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects J Child Neurol, 19(S1), S6-S14.
161. Sankar, R., Shin, D.H. & Wasterlain, C.G. (1997). GABA metabolism during status epilepticus in the developing rat brain. Dev Brain Res, 98, 60-64.
162. Sato, M., Racine, R.J. & McIntyre, D.C. (1990). Kindling: basic mechanisms and clinical validity. Electroenceph Clin Neurophysiol, 76, 459-472.
163. Sayin, U., Osting, S., Hagen, J., Rutecki, P. & Sutula, T. (2003). Spontaneous seizures and loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled rats. J Neurosci, 23, 2759-2768.
164. Schauwecker, P.E. & Steward, O. (1997). Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches Proc Natl Acad Sci USA, 94, 4103-4108.
165. Schinder, A. & Mu-ming, P. (2000). The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci, 23, 639-645.
166. Schwarcz, R. & Witter, M. (2002). Is neurodegeneration responsible for memory and behavioral alterations in epilepsy? Epilepsy Res, 50(1-2), 161-177.
167. Schwarzer, C.&Sperk, G. (1998). Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors. Hippocampus, 8, 274-288. (Pubitemid 28288859)
168. Shetty, A.K. (2004). Progenitor cells from the CA3 region of the embryonic day 19 rat hippocampus generate region-specific neuronal phenotypes in vitro. Hippocampus, 14, 595-614.
169. Shetty, A.K. & Hattiangady, B. (2007). Concise review: prospects of stem cell therapy for temporal lobe epilepsy. Stem Cells, 25(10), 2396-23407.
170. Sisodiya, S., Lin,W.R., Harding, B., Squier,W.&Thom, M. (2002). Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain, 125, 22-31.
171. Stefovska, V.G., Uckermann, O., Czuczwar, M., Smitka, M., Czuczwar, P., Kis, J., Kaindl, A.M., Turski, L., Turski,W.A.& Ikonomidou, C. (2008) Oct. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol, 64(4), 434-445
172. Suchomelova, L., Baldwin, R.A., Kubova, H., Thompson, K.W., Sankar, R. & Wasterlain, C.G. (2006). Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. Pediatr Res, 59(2), 237-243.
173. Sullivan, P.G., Dube, C., Dorenbos, K., Steward, O. & Baram, T.Z. (2003). Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol, 53, 711-717.
174. Sutula, T. (2002). Antiepileptic drugs to prevent neural degeneration associated with epilepsy: assessing the prospects for neuroprotection. Epilepsy Res, 50, 125-129.
175. Sutula, T., Cavazos, J. & Golarai, G. (1992). Alteration of longlasting structural and functional effects of kainic acid in the hippocampus by brief treatment with Phenobarbital. J Neurosci, 12, 4173-4187.
176. Swann, J.W. & Mosh́e, S.L. (1997). Developmental issues in animal models. In: Engel, J. Jr, Pedley, T.A., eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers, pp. 467-480.
177. Tandon, P., Yang, Y., Das, K., Holmes, G.L. & Stafstrom, C.E. (1999). Neuroprotective effects of brain-derived neurotrophic factor in seizures during development. Neuroscience, 91, 293-303.
178. Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., Okuyama, S., Kawashima, N., Hori, S., Takimoto, M. &Wada. K. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science, 276, 1699-1702.
179. Tein, I. & MacGrgor, D.L. (1985). Possible valproate teratogenecity. Arch Neurol, 42, 291-293.
180. Temkin, N.R. (2001). Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia, 42, 515-524.
181. Thompson, H.J., Lifshitz, J., Marklund, N., Grady, M.S., Graham, D.I., Hovda, D.A. & McIntosh, T.K. (2005). Lateral fluid percussion brain injury: a 15-year review and evaluation. J Neurotrauma, 22, 42-75.
182. Trojnar, M.K., Malek, R., Chroscinska, M., Nowak, S., Blaszczyk, B. & Czuczwar, S.J. (2002). Neuroprotective effects of antiepileptic drugs. Pol J Pharmacol, 54, 557-566.
183. Turski, W.A., Czuczwar, S.J., Kleinrok, Z. & Turski, L. (1983). Cholinomimetics produce seizures and brain damage in rats. Experientia, 39(12), 1408-1411. (Pubitemid 14203754)
184. Turski, W.A., Cavalheiro, E.A., Bortolotto, Z.A., Mello, L.M., Schwarz, M. & Turski, L. (1984). Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res, 321(2), 237-253.
185. Van Eldik, L.J. & Wainwright, M.S. (2003). The Janus face of glial-derived S-100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci, 21, 97-108.
186. Verhagen, A.M., Ekert, P.G., Pakusch, M., Silke, J., Connolly, L.M., Reid, G.E., Moritz, R.L., Simpson, R.J. & Vaux, D.L. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102, 43-53.
187. Vezzani, A., Ravizza, T., Moneta, D., Conti, M., Borroni, A., Rizzi, M., Samanin, R.&Maj, R. (1999). Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: temporal evolution of changes as compared to neuropeptide Y. Neuroscience, 90, 1445-1461.
188. Wang, Q., Maloof, P., Wang, H., Fenig, E., Stein, D., Nichols, G., Denny, T.N.,Yahalom, J.&Wieder, R. (1998). Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Exp Cell Res, 38, 177-187.
189. Wang, C.D. & Jensen, F.E. (1996). NMDA involvement in agedependent differences in seizure susceptibility in hippocampal slices. Epilepsy Res, 23, 105-113.
190. Wasterlain, C.G., Adams, L.M., Wichmann, J.K. & Sofia, R.D. (1996). Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia. Stroke, 27, 1236-1240.
191. Wasterlain, C.G., Niquet, J., Thompson, K.W., Baldwin, R., Liu, H., Sankar, R., Mazarati, A.M., Naylor, D., Katsumori, H., Suchomelova, L. & Shirasaka, Y. (2002). Seizure-induced neuronal death in the immature brain. Prog Brain Res, 135, 335-353.
192. Watanabe, Y., Gould, E., Cameron, H.A., Daniels, D.C.&McEwen, B.S. (1992). Phenytoin prevents stress- and corticosteroneinduced atrophy of CA3 pyramidal neurons. Hippocampus, 2(4), 431-435.
193. Watson, D.G., Watterson, J.M. & Lenox, R.H. (1998). Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers. J Pharmacol Exp Ther, 285(1), 307-316.
194. White, H.S., Woodhead, J.H., Franklin, M.R., Swinyard, E.A. & Wolf, H.H. (1995). Experimental selection, quantification, and evaluation of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS. (Eds.), Antiepileptic Drugs, fourth ed. Raven Press, New York, pp. 99-110.
195. Wieser, H.G. (2004). ILAE Commission Report: mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia, 45, 695-714.
196. Willmore, L.J. & Rubin, J.J. (1981). Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies. Neurology, 31, 63-69.
197. Wyatt, S., Mailhos, C. & Latchman, D.S. (1996). Trigeminal ganglion neurons are protected by the heat shock proteins hsp70 and hsp90 from thermal stress but not from programmed cell death following nerve growth factor withdrawal. Brain Res Mol Brain Res, 39, 52-56.
198. Xapelli, S., Agasse, F., Ferreira, R., Silva, A.P. & Malva, J.O. (2006). Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide, Recent Patents CNS Drug Discov, 1(3), 315-324.
199. Xiao, Y. & Li, X. (1999). Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res, 846(1), 112-121.
200. Xu, L. & Giffard, R.G. (1997). HSP70 protects murine astrocytes from glucose deprivation injury. Neurosci Lett, 224, 9-12.
201. Yakovlev, A.G. & Faden, A.I. (2004). Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx, 1, 5-16.
202. Yang, T., Hsu, C., Liao, W. & Chuang, J.S. (2008). Heat shock protein 70 expression in epilepsy suggests stress rather than protection. Acta Neuropathol, 115(2), 219-230.
203. Yasuhara, T., Matsukawa, N., Yu, G., Xu, L., Mays, R.W., Kovach, J., Deans, R.J., Hess, D.C., Carroll, J.E. & Borlongan, C.V. (2006). Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant, 15, 231-238.
204. Yenari, M.A. (2002). Heat shock proteins and neuroprotection. Adv Exp Med Biol, 513, 281-299.
205. Yokoi, I., Kabuto, H., Yamamoto, M. & Mori, A. (1990). Effect of ferric iron and active oxygen scavenger on monoamine release in the striatum of the rat. Jpn J Psychiatry Neurol, 44, 440-441.
206. Yoshida, H., Yanai, H., Namiki, Y., Fukatsu-Sasaki, K., Furutani, N. & Tada, N. (2006). Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev, 12(1), 9-20.
207. Young, B., Rapp, R.P., Normn, J.A., Haack, D., Tibbs, P.A.& Bean, J.R. (1983). Failure of prophylactically administered phenytoin to prevent the late post traumatic seizures. J Neurosurgery, 58, 236-241. (Pubitemid 13190258)
208. Yu, X., Shao, X.G., Sun, H., Li, Y.N., Yang, J., Deng, Y.C.&Huang, Y.G. (2008). Activation of cerebral peroxisome proliferatoractivated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus. Brain Res, 1200, 146-158.
209. Zhang, G., Raol, Y., Hsu, F.-C., Coulter, D. & Brooks-Kayal, A. (2004a). Effects of status epilepticus on hippocampal GABAA receptors are age-dependent. Neuroscience, 125, 299-303.
210. Zhang, H., Yang, Q. & Xu, C. (2004b). Effect of chronic stress and phenytoin on the long-term potentiation (LTP) in rat hippocampal CA1 region. Acta Biochimica et Biophysica Sinica, 36(5), 375-378.
211. Zhang, X., Smith, M.A., Li, X.L.,Weiss, S.R. & Post, R.M. (1998). Apoptosis of hippocampal neurons after amygdala kindled seizures. Brain Res Mol Brain Res, 55, 198-208.
212. Zhang, X., Velumian, A.A., Jones, O.T. & Carlen, P.L. (2000). Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia, 41(S1), S52-S60.
213. Zhang, R.L., Chopp, M., Zhang, Z.G., Jiang, Q. & Ewing, J.R. (1997). A rat model of focal embolic cerebral ischemia. Brain Res, 766, 83-92. (Pubitemid 27431437)
214. Zivin, J.A. & Grotta, J.C. (1990). Animal stroke models. They are relevant to human disease. Stroke, 21, 981-983.
215. Zwienenberg, M., Gong, Q.-Z., Berman, R.F., Muizelaar, J.P. & Lyeth, B.G. (2001). The effect of groups II and III metabotropic glutamate receptor activation on neuronal injury in a rodent model of traumatic brain injury. Neurosurgery, 48, 1119-1127.